Omeat produces real meat by growing cells outside of animals, offering a humane alternative to conventional production. This cultivated beef provides the same protein and nutrients as traditional meat but with reduced saturated fat and without GMOs, antibiotics, or hormones. The company's process focuses on efficiency to deliver a better meat product for consumers and the planet.
Funding
$40M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional meat production methods raise ethical and environmental concerns, requiring significant land use and contributing to greenhouse gas emissions. Current cell-based meat production often relies on expensive growth mediums like fetal bovine serum (FBS), hindering scalability and cost-effectiveness.
Solution
Omeat is developing a cultivated beef product using a novel approach that significantly reduces the reliance on traditional animal agriculture. The company extracts regenerative growth factors from cow plasma, collected weekly from a regenerative farm, to create a cost-effective growth medium. This plasma-derived medium replaces the need for FBS, enabling the cultivation of real beef cells in bioreactors. Omeat's process aims to deliver a sustainable and humane alternative to conventionally produced meat, with a focus on reducing environmental impact and improving production efficiency.
Target Audience
Omeat's target audience includes environmentally conscious consumers, food manufacturers, and retailers seeking sustainable and ethical meat alternatives.
Features
- Proprietary method for extracting growth factors from cow plasma as a replacement for FBS
- Use of regenerative agriculture practices for sourcing plasma from healthy, free-roaming cattle
- Cell-cultivation process in bioreactors to grow real beef cells
- Production of ground beef with reduced saturated fat and no GMOs, antibiotics, or hormones
- Patent-pending technology applicable to the cultivation of beef, pork, chicken, and fish
- Pilot plant under development with capacity for 2,000-liter and 10,000-liter bioreactors